Mary Claire Haver, MD, FACOG, MSCP, is a board-certified OB-GYN and Menopause Society Certified Practitioner
Providers can encourage patients to be prepared for potential setbacks and have a plan in place to get back on track if they start to regain weight, Rose said.
MET-224o, an ultra-long acting GLP-1 RA being developed to be administered at lower dose levels than other oral peptides developed through Metseras Nutrient Stimulated Hormone (NuSH) platform, to improve scalability
But new research focusing specifically on people with bipolar is beginning to provide some answers
Explore Weight Loss Support Options New medications like retatrutide highlight how quickly weight management treatments are evolving
For budget-constrained individuals, the lower price point is appealing